当前蛋白身份:P06241 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
10DJ Fyn Kinase Domain-Saracatinib Complex Structure 提交 2026-01-13 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 263–537(275 aa)
未记录 H8H N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;4.0 M ammonium acetate, 0.1 M sodium acetate trihydrate, pH 4.6
分辨率 2.22 Å R-free 0.268
10DJ Fyn Kinase Domain-Saracatinib Complex Structure 提交 2026-01-13 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 263–537(275 aa)
未记录 H8H N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;4.0 M ammonium acetate, 0.1 M sodium acetate trihydrate, pH 4.6
分辨率 2.22 Å R-free 0.268
1A0N NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE COMPLEXED WITH THE SYNTHETIC PEPTIDE P2L CORRESPONDING TO RESIDUES 91-104 OF THE P85 SUBUNIT OF PI3-KINASE, FAMILY OF 25 STRUCTURES 提交 1997-12-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 79–147(69 aa) 片段:SH3 DOMAIN, RESIDUES 82 - 148
突变:N-TERMINAL GS FROM EXPRESSION SYSTEM 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1AOT NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, MINIMIZED AVERAGE STRUCTURE 提交 1997-07-10 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 142–247(106 aa) 片段:SH2 DOMAIN
突变:C97S, C98S, C104S 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6;293 K
分辨率未提供
1AOU NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES 提交 1997-07-10 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 142–247(106 aa) 片段:SH2 DOMAIN
突变:C97S, C98S, C104S 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6;293 K
分辨率未提供
1AVZ V-1 NEF PROTEIN IN COMPLEX WITH WILD TYPE FYN SH3 DOMAIN 提交 1997-09-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 84–140(57 aa) 片段:SRC-HOMOLOGY 3 DOMAIN
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 8.9;pH 8.9
分辨率 3.00 Å R-free 0.270
1AZG NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE KINASE COMPLEXED WITH THE SYNTHETIC PEPTIDE P2L CORRESPONDING TO RESIDUES 91-104 OF THE P85 SUBUNIT OF PI3-KINASE, MINIMIZED AVERAGE (PROBMAP) STRUCTURE 提交 1997-11-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 81–147(67 aa) 片段:SH3 DOMAIN, RESIDUES 82 - 148
突变:N-TERMINAL GS FROM EXPRESSION SYSTEM 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1EFN HIV-1 NEF PROTEIN IN COMPLEX WITH R96I MUTANT FYN SH3 DOMAIN 提交 1996-06-29 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 85–142(58 aa) 片段:SH3 DOMAIN, RESIDUES 85-141
链 C 85–142(58 aa) 片段:SH3 DOMAIN, RESIDUES 85-141
突变:R96I 突变:R96I PBM TRIMETHYL LEAD ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.50 Å R-free 0.282
1FYN PHOSPHOTRANSFERASE 提交 1995-05-17 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 80–141(62 aa) 片段:SH3 DOMAIN
未记录 未记录非水小分子 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.30 Å
1G83 CRYSTAL STRUCTURE OF FYN SH3-SH2 提交 2000-11-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 81–245(165 aa) 片段:SH3 AND SH2 DOMAIN
突变:C238S, C239S, C245S 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6;295 K;PEG 8000, sodium tartrate, TRIS , pH 6.0, VAPOR DIFFUSION, temperature 295.0K
分辨率 2.60 Å R-free 0.277
1G83 CRYSTAL STRUCTURE OF FYN SH3-SH2 提交 2000-11-16 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 81–245(165 aa) 片段:SH3 AND SH2 DOMAIN
突变:C238S, C239S, C245S 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6;295 K;PEG 8000, sodium tartrate, TRIS , pH 6.0, VAPOR DIFFUSION, temperature 295.0K
分辨率 2.60 Å R-free 0.277
1M27 Crystal structure of SAP/FynSH3/SLAM ternary complex 提交 2002-06-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 83–143(61 aa) 片段:SH3 domain (residues 82-143)
未记录 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.6;297 K;Tartrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 297K
分辨率 2.50 Å R-free 0.266
1NYF NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, MINIMIZED AVERAGE (PROBMAP) STRUCTURE 提交 1996-04-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 81–147(67 aa) 片段:SH3 DOMAIN, RESIDUES 82 - 148
突变:INS(GS-T82) 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1NYG NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, FAMILY OF 20 STRUCTURES 提交 1996-04-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 81–147(67 aa) 片段:SH3 DOMAIN, RESIDUES 82 - 148
突变:INS(GS-T82) 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1SHF CRYSTAL STRUCTURE OF THE SH3 DOMAIN IN HUMAN FYN; COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF SH3 DOMAINS IN TYROSINE KINASES AND SPECTRIN 提交 1993-05-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 83–141(59 aa)
链 B 83–141(59 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.90 Å
1ZBJ Inferential Structure Determination of the Fyn SH3 domain using NOESY data from a 15N,H2 enriched protein 提交 2005-04-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–141(59 aa) 片段:SH3 domain, Residues 83-141
未记录 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
2DQ7 Crystal Structure of Fyn kinase domain complexed with staurosporine 提交 2006-05-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 X 261–537(277 aa) 片段:Fyn, Protein kinase
非标准单体:是(mmCIF未提供具体位点) STU STAUROSPORINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;277 K;1.15M ammonium sulfate, 0.2M NaCl, 0.1M imidazole, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K
分辨率 2.80 Å R-free 0.281
2MQI human Fyn SH2 free state 提交 2014-06-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 148–248(101 aa) 片段:UNP residues 149-248
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6.5;298 K;离子强度(mmCIF原始值)50;压力 ambient
NMR样品组成 0.8-1.4 mM [U-13C; U-15N] FynSH2, 50 mM sodium phosphate, 5 mM DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
分辨率未提供
2MRJ Structure of Fyn protein SH2 bound 提交 2014-07-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 148–248(101 aa) 片段:UNP residues 149-248
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6.5;298 K;离子强度(mmCIF原始值)0;压力 ambient
NMR样品组成 1 mM [U-99% 13C; U-99% 15N] FynSH2 bound, 93% H2O/7% D2O | 93% H2O/7% D2O
分辨率未提供
2MRK Fyn SH2 domain in complex with the natural inhibitory phosphotyrosine peptide 提交 2014-07-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 149–248(100 aa) 片段:UNP residues 149-248
链 B 528–537(10 aa) 片段:UNP residues 528-537
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 6.5;298 K;离子强度(mmCIF原始值)0;压力 ambient
NMR样品组成 0.93 mM [U-99% 13C; U-99% 15N] protein_1, 1.2 mM protein_2, 93% H2O/7% D2O | 93% H2O/7% D2O
分辨率未提供
3H0F Crystal structure of the human Fyn SH3 R96W mutant 提交 2009-04-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 73–142(70 aa) 片段:SH3 domain, UNP residues 73-142
突变:R96W PG5 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 9.1;277 K;2.0M ammonium sulphate, 2% PEG 400, 0.1M Tris, pH 9.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.61 Å R-free 0.282
3H0H human Fyn SH3 domain R96I mutant, crystal form I 提交 2009-04-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 73–142(70 aa) 片段:SH3 domain, UNP residues 73-142
突变:R96I PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;0.5M ammonium sulphate, 0.1M sodium citrate, 1.0M lithium sulphate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 1.76 Å R-free 0.222
3H0I human Fyn SH3 domain R96I mutant, crystal form II 提交 2009-04-09 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 73–142(70 aa) 片段:SH3 domain, UNP residues 73-142
突变:R96I 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;0.2M ammonium acetate, 0.1M TRIS, 30% v/v MPD, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.20 Å R-free 0.243
3H0I human Fyn SH3 domain R96I mutant, crystal form II 提交 2009-04-09 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 73–142(70 aa) 片段:SH3 domain, UNP residues 73-142
突变:R96I 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;0.2M ammonium acetate, 0.1M TRIS, 30% v/v MPD, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.20 Å R-free 0.243
3UA6 Crystal Structure of the Human Fyn SH3 domain 提交 2011-10-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 GOL GLYCEROL × 2 FMT FORMIC ACID × 5 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;5.5 M sodium formate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.85 Å R-free 0.246
3UA6 Crystal Structure of the Human Fyn SH3 domain 提交 2011-10-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 FMT FORMIC ACID × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;5.5 M sodium formate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.85 Å R-free 0.246
3UA7 Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus NS5A-protein 提交 2011-10-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 GOL GLYCEROL × 1 CL CHLORIDE ION × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;4 M sodium formate, 10 mM zinc chloride, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.50 Å R-free 0.231
3UA7 Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus NS5A-protein 提交 2011-10-21 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 ZN ZINC ION × 1 FMT FORMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;4 M sodium formate, 10 mM zinc chloride, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.50 Å R-free 0.231
3UA7 Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus NS5A-protein 提交 2011-10-21 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;4 M sodium formate, 10 mM zinc chloride, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.50 Å R-free 0.231
3UA7 Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus NS5A-protein 提交 2011-10-21 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 ZN ZINC ION × 1 FMT FORMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;4 M sodium formate, 10 mM zinc chloride, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.50 Å R-free 0.231
4D8D Crystal structure of HIV-1 NEF Fyn-SH3 R96W variant 提交 2012-01-10 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 84–141(58 aa) 片段:SRC-HOMOLOGY 3 DOMAIN (UNP Residues 84-141)
突变:R96W 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.4;293 K;0.3 M sodium potassium tartrate, 0.5 M bicine buffer , 1cmc D-octylglucopyranoside, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.52 Å R-free 0.238
4D8D Crystal structure of HIV-1 NEF Fyn-SH3 R96W variant 提交 2012-01-10 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 84–141(58 aa) 片段:SRC-HOMOLOGY 3 DOMAIN (UNP Residues 84-141)
突变:R96W GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.4;293 K;0.3 M sodium potassium tartrate, 0.5 M bicine buffer , 1cmc D-octylglucopyranoside, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.52 Å R-free 0.238
4EIK Crystal Structure of the Human Fyn SH3 domain in complex with the synthetic peptide VSL12 提交 2012-04-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 81–143(63 aa) 片段:SH3 domain (UNP residues 81-143)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;5.5 M sodium formate, 0.1 M MES, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.60 Å R-free 0.195
4U17 Swapped dimer of the human Fyn-SH2 domain 提交 2014-07-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:Dimeric(2) 与蛋白数一致
链 A 148–248(101 aa) 片段:Fyn-SH2 domain (UNP residues 148-248)
链 C 148–248(101 aa) 片段:Fyn-SH2 domain (UNP residues 148-248)
未记录 PO4 PHOSPHATE ION × 5 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;50 mM sodium phosphate pH 6.5
分辨率 1.99 Å R-free 0.255
4U17 Swapped dimer of the human Fyn-SH2 domain 提交 2014-07-15 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:Dimeric(2) 与蛋白数一致
链 B 148–248(101 aa) 片段:Fyn-SH2 domain (UNP residues 148-248)
未记录 PO4 PHOSPHATE ION × 4 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;50 mM sodium phosphate pH 6.5
分辨率 1.99 Å R-free 0.255
4U1P Human Fyn-SH2 domain in complex with a synthetic high-affinity phospho-peptide 提交 2014-07-16 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:DIMERIC(2) 与蛋白数一致
链 A 148–248(101 aa) 片段:Human Fyn-SH2 domain, RESIDUES 148-248
未记录 15P POLYETHYLENE GLYCOL (N=34) × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MOPS/Na HEPES pH 7.5, 0.12 M monosaccharide mixture, PEG 1000, 12.5%(w/v) PEG 3350 and 12.5%(v/v) MPD
分辨率 1.40 Å R-free 0.188
4ZNX Crystal structure of the Fyn-SH3 domain in complex with the high affinity peptide APP12 提交 2015-05-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 84–141(58 aa) 片段:SH3 DOMAIN, UNP residues 84-141
链 B 84–141(58 aa) 片段:SH3 DOMAIN, UNP residues 84-141
链 C 84–141(58 aa) 片段:SH3 DOMAIN, UNP residues 84-141
链 D 84–141(58 aa) 片段:SH3 DOMAIN, UNP residues 84-141
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4 M sodium formate, 0.1 M Hepes
分辨率 2.10 Å R-free 0.222
5ZAU Complex of the human FYN SH3 and monobody binder 提交 2018-02-09 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 85–141(57 aa) 片段:UNP residues 85-141
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 8;298 K;离子强度(mmCIF原始值)300;压力 1
NMR样品组成 1 mM [U-99% 13C; U-99% 15N] FYN SH3 domain, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 1 mM [U-99% 13C; U-99% 15N] Monobody Binder, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 1 mM [U-99% 15N; U-98% 2H] FYN SH3 domain, 1.5 mM Unlabeled Monobody Binder, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 0.2 mM [U-99% 15N] FYN SH3 domain, 1 mM Unlabeled Monobody Binder, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR样品组成 0.2 mM [U-99% 15N] Monobody Binder, 1 mM Unlabeled FYN SH3 domain, 90% H2O/10% D2O | 90% H2O/10% D2O
分辨率未提供
6IPY His-tagged Fyn SH3 domain R96I mutant 提交 2018-11-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 82–144(63 aa) 片段:UNP residues 82-144
突变:R96I 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 3.5;295 K;0.1M Citric acid pH 3.5 and 25%(w/v) Polyethylene glycol 3,350
分辨率 1.34 Å R-free 0.201
6IPZ Fyn SH3 domain R96W mutant, crystallized with 18-crown-6 提交 2018-11-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 Z 82–144(63 aa) 片段:UNP residues 82-144
突变:R96W O4B 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.6;295 K;0.08M Sodium acetate trihydrate pH 4.6, 1.6M Ammonium sulfate, 20%(v/v) Glycerol
分辨率 1.58 Å R-free 0.209
7A2J Crystal structure of the Fyn SH3 domain in space group C21 at pH 7.5 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4.5M sodium formate, 0.1M Hepes
分辨率 1.50 Å R-free 0.247
7A2J Crystal structure of the Fyn SH3 domain in space group C21 at pH 7.5 提交 2020-08-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 83–142(60 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4.5M sodium formate, 0.1M Hepes
分辨率 1.50 Å R-free 0.247
7A2K Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4.5M sodium formate, 0.1M Hepes
分辨率 1.50 Å R-free 0.236
7A2K Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5 提交 2020-08-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 83–142(60 aa)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4.5M sodium formate, 0.1M Hepes
分辨率 1.50 Å R-free 0.236
7A2K Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5 提交 2020-08-18 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 83–142(60 aa)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4.5M sodium formate, 0.1M Hepes
分辨率 1.50 Å R-free 0.236
7A2K Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5 提交 2020-08-18 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 83–142(60 aa)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;4.5M sodium formate, 0.1M Hepes
分辨率 1.50 Å R-free 0.236
7A2L Crystal structure of the Fyn SH3 domain mutant E129Q in space group C21 at pH 4.0 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
突变:E129Q FMT FORMIC ACID × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;3.5M sodium formate, 0.1M sodium acetate
分辨率 1.90 Å R-free 0.261
7A2L Crystal structure of the Fyn SH3 domain mutant E129Q in space group C21 at pH 4.0 提交 2020-08-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 83–142(60 aa)
突变:E129Q 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;3.5M sodium formate, 0.1M sodium acetate
分辨率 1.90 Å R-free 0.261
7A2M Crystal structure of the Fyn SH3 domain A95S-D99T mutant in C21 space group 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
突变:A95S D99T NA SODIUM ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;4.5 M sodium formate, 0.1 sodium acetate
分辨率 1.50 Å R-free 0.255
7A2M Crystal structure of the Fyn SH3 domain A95S-D99T mutant in C21 space group 提交 2020-08-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 83–142(60 aa)
突变:A95S D99T NA SODIUM ION × 1 FMT FORMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;4.5 M sodium formate, 0.1 sodium acetate
分辨率 1.50 Å R-free 0.255
7A2N Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
突变:A95S D99T FMT FORMIC ACID × 1 NA SODIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;4.5 M sodium formate, 0.1 sodium acetate
分辨率 1.40 Å R-free 0.203
7A2N Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21 提交 2020-08-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 83–142(60 aa)
突变:A95S D99T FMT FORMIC ACID × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;4.5 M sodium formate, 0.1 sodium acetate
分辨率 1.40 Å R-free 0.203
7A2N Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21 提交 2020-08-18 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 83–142(60 aa)
突变:A95S D99T FMT FORMIC ACID × 3 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;4.5 M sodium formate, 0.1 sodium acetate
分辨率 1.40 Å R-free 0.203
7A2N Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21 提交 2020-08-18 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 83–142(60 aa)
突变:A95S D99T FMT FORMIC ACID × 3 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;4.5 M sodium formate, 0.1 sodium acetate
分辨率 1.40 Å R-free 0.203
7A2O Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.5 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
突变:L112V S114N S115T E121L R123H PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;298 K;5% PEG 300, 1.5 ammonium sulfate, 0.1M sodium acetate
分辨率 0.94 Å R-free 0.175
7A2P Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0 with PEG 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–143(61 aa)
突变:L112V S114N S115T E121L R123H PGE TRIETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;5% PEG 300, 2.0 ammonium sulfate, 0.1M sodium acetate
分辨率 0.90 Å R-free 0.150
7A2Q Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 3.0 with PEG 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–143(61 aa)
突变:L112V S114N S115T E121L R123H PG4 TETRAETHYLENE GLYCOL × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;5% PEG 300, 5 mM beta-cyclodextrin, 2.0 ammonium sulfate, 0.1M sodium citrate
分辨率 0.94 Å R-free 0.161
7A2R Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 6.0 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–143(61 aa)
突变:L112V S114N S115T E121L R123H 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1.5 ammonium sulfate, 0.1M MES
分辨率 1.05 Å R-free 0.173
7A2S Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–143(61 aa)
突变:L112V S114N S115T E121L R123H 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;2.0 ammonium sulfate, 0.1M sodium acetate
分辨率 1.02 Å R-free 0.175
7A2T Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.0 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–143(61 aa)
突变:L112V S114N S115T E121L R123H ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;1 ammonium sulfate, 0.1M sodium acetate
分辨率 1.22 Å R-free 0.203
7A2U Crystal structure of the Fyn SH3 domain L112V-S114N-S115T at pH 4.5 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
突变:L112V S114N S115T ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;298 K;1.5 M ammonium sulfate, 0.1 sodium acetate
分辨率 1.70 Å R-free 0.200
7A2V Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E129Q at pH 4.0 提交 2020-08-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 83–142(60 aa)
突变:L112V S114N S115T E129Q 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;1.5 M ammonium sulfate, 0.1 sodium acetate
分辨率 1.81 Å R-free 0.220
7A2W Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 at pH 3.0 提交 2020-08-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 83–142(60 aa) 片段:SH3 domain
突变:L112V S114N S115T E121L R123H CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 3;298 K;0.5 M ammonium sulfate, 0.1 sodium citrate
分辨率 0.99 Å R-free 0.151
7A2X Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 at pH 5.0 提交 2020-08-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 83–142(60 aa) 片段:SH3 domain
突变:L112V S114N S115T E121L R123H 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;0.5 M ammonium sulfate, 0.1 sodium acetate
分辨率 0.92 Å R-free 0.148
7A2Y Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 at pH 4.0 提交 2020-08-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 83–142(60 aa) 片段:SH3 domain
突变:L112V S114N S115T E121L R123H 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;298 K;0.5 M ammonium sulfate, 0.1 sodium acetate
分辨率 0.97 Å R-free 0.146
7A2Z Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 at pH 6.0 提交 2020-08-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 83–142(60 aa) 片段:SH3 domain
突变:L112V S114N S115T E121L R123H 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1 M ammonium sulfate, 0.1 sodium acetate
分辨率 1.14 Å R-free 0.195
8KDX Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current 提交 2023-08-10 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 85–142(58 aa) 片段:FynSH3 domain
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293.15 K;1.2 M Sodium citrate tribasic dehydrated, 0.1 M Tris buffer pH8.5
分辨率 1.01 Å R-free 0.185
9GHK Crystal structure of Fyn SH3 domain/tau 214-220 peptide complex 提交 2024-08-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 80–143(64 aa)
链 B 80–143(64 aa)
未记录 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M NaCl, 0.4 M NaH2PO4, 1.5 M K2HPO4, 0.1 M imidazole pH 7.5
分辨率 1.42 Å R-free 0.218
9PGZ X-ray crystal structure of SRD42 提交 2025-07-08 Assembly 1 信息不足 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 87–141(55 aa)
未记录 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;279 K;0.5 M Sodium chloride, 0.01 M Hexadecyltrimethylammonium bromide
分辨率 2.60 Å R-free 0.247